Updates from ASRS 2021
These podcasts are an editorially independent initiative with support by Roche. To learn more about Roche Ophthalmology, visit www.futureofvision.global
Updates from ASRS 2021: The FDA-Approved Port Delivery System
Note: This podcast was recorded prior to FDA approval.
Presented by:
Carl C. Awh, MD, FASRS
Carl D. Regillo, MD, FACS
Carl C. Awh, MD, FASRS
Carl C. Awh, MD, FASRS is an internationally recognized clinician, surgeon, and educator. He holds 12 U.S. patents for retinal surgical devices and treatments and has designed dozens of instruments in widespread use by vitreoretinal surgeons. He serves on the Executive Committee and is the President of the American Society of Retina Specialists. He is a past member of the board of EURETINA, the European Retina Society. Dr. Awh was inducted as an inaugural member of the Retina Hall of Fame in 2017.
Carl D. Regillo, MD, FACS
Carl D. Regillo, MD, FACS is Chief of the Retina Service at Wills Eye Hospital. Dr. Regillo is currently Director of the Retina Service and Professor of Ophthalmology at Thomas Jefferson University School of Medicine. Dr. Regillo has authored more than 100 scientific papers, lectured nationally and abroad, and has published five major textbooks in the field. He is a recipient of the American Academy of Ophthalmology's Achievement and Senior Achievement Awards in addition to the Secretariat Award.
Updates from ASRS 2021: Real-World Use of Anti-VEGFs and Outcomes in AMD, DME
Presented by:
Parisa Emami-Naeini, MD, MPH
Theodore Leng, MD, PhD
Parisa Emami-Naeini, MD, MPH
Parisa Emami-Naeini, MD, MPH, is the Director of the Uveitis and Ocular Inflammation Service, and an Assistant Professor at University of California/Davis. Dr. Emami's research interests include retinal imaging, pathogenesis and management of ocular inflammation/uveitis. She is the recipient of the UC Davis Innovative Development Award, 2021, and is a previous Ophthalmology Times Research Scholar Honoree (2017).
Theodore Leng, MD, PhD
Theodore Leng, MD, PhD, is an associate professor of ophthalmology and, by courtesy, of anesthesiology, perioperative, and pain medicine (Adult MSD) at Stanford Hospital and Clinics in California. He is considered to be one of the top 150 worldwide leading innovators in the field of medical and surgical retina and serves the Department of Ophthalmology as both the Director of Clinical and Translational Research and the Director of Ophthalmic Diagnostics.
Updates from ASRS 2021: Faricimab Clinical Study Data to Date
Note: This podcast was recorded prior to FDA approval.
Presented by:
Caroline R. Baumal, MD
Karl Csaky, MD, PhD
Caroline R. Baumal, MD
Caroline R. Baumal, MD is an Associate Professor of Ophthalmology and Director of Retinopathy of Prematurity Service at New England Eye Center, Tufts Medical Center in Boston, MA. Her research interests include novel retinal imaging and drug development, which are a continuation from her fellowship research using the first prototype OCT and working with drug implants and photodynamic therapy. Her clinical interests include age-related maculopathy, diabetic retinopathy, complex vitreoretinal surgery and retinopathy of prematurity. Dr. Baumal has authored more than 100 publications and 28 book chapters on retinal diseases, and has recently edited the book Treatment of Diabetic Retinopathy.
Karl Csaky, MD, PhD
Karl Csaky, MD, PhD, is the T. Boone Pickens Director/Managing Director and Chief Medical Officer of the Retina Foundation of the Southwest in Dallas, Texas. He has been involved in numerous clinical trials on dry AMD and inherited retinal diseases, and is currently studying vision function assessments of patients with various retinal diseases and developing drug delivery approaches for the treatment of retinal diseases. Dr. Csaky has more than 120 peer-reviewed publications and book chapters.
